-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Acquired Bleeding Disorders in the Elderly

Program: Education Program
Session: Management of Challenging Bleeding Complications
Saturday, December 5, 2015, 7:30 AM-9:00 AM
Chapin Theater (W320), Level 3 (Orange County Convention Center)
Saturday, December 5, 2015, 4:00 PM-5:30 PM
W308, Level 3 (Orange County Convention Center)

Rebecca Kruse-Jarres, MD, MPH

Washington Center for Bleeding Disorders at BloodWorks NW, University of Washington, Seattle, WA

Disclosures: Kruse-Jarres: Pfizer: Consultancy , Honoraria ; Novo Nordisk: Consultancy , Honoraria ; Roche: Consultancy , Honoraria ; CSL Behring: Consultancy , Honoraria ; Octapharma: Consultancy , Honoraria ; Bayer: Consultancy , Honoraria ; Baxter: Consultancy , Honoraria . Off Label Use: rituximab for the treatment for acquired hemophilia.

See more of: Management of Challenging Bleeding Complications
See more of: Education Program
Previous Presentation | Next Presentation >>